Answers are grounded in this paper and cite their sources.
Systematic review demonstrates better outcomes with intravenous corticosteroids in Graves' ophthalmopathy, suggesting a need for further trials.
IV steroids were associated with more favourable outcomes and better tolerability than oral steroids in moderate-to-severe GO. Further comprehensive trials are needed to confirm long-term safety and optimize treatment protocols.
No takes yet. Share an insight, caveat, or question.
Almutairi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: